Sartorius and BD Diagnostics plan to collaborate on ready-to-use, prefilled media products for microbiological applications.
Sartorius Stedim Biotech and BD Diagnostics, a segment of BD (Becton, Dickinson and Company) a medical technology company, reported a collaboration to develop, manufacture, and market various ready-to-use, prefilled media products for microbiological applications in pharmaceutical, biotech, and research laboratories.
As part of this collaboration, BD will fill special Sartorius single-use products with BD culture media and supply these to Sartorius as prepackaged products. Both companies are looking to further extend their existing business relationship by pursuing other solutions in the field of microbiological diagnostics.
Source: Sartorius Stedim Biotech
New Cancer Research and Treatment Center in Development in London
May 1st 2025Aviva Capital Partners and developer Socius are investing £1 billion in a 12-acre site to be located at the London Cancer Hub next to The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust’s Sutton site.